不插管与仅舒适治疗医嘱患者中的无创通气:系统评价与Meta分析
该系统评价与Meta分析检索MEDLINE、EMBASE、CINAHL、Scopus和Web of Science至2017年1月1日,纳入27项研究2020例不插管医嘱患者和3项研究200例仅舒适治疗医嘱患者。不插管医嘱患者无创通气后合并出院存活率56%(95%CI 49-64%),1年存活率32%(95%CI 21-45%);COPD和肺水肿患者出院存活率均为68%,肺炎41%,恶性肿瘤37%;普通病房与ICU治疗者存活率相当。幸存者生活质量较基线未降低,但评估研究很少;无研究评估死亡质量。仅舒适治疗医嘱患者中,单项研究显示无创通气与呼吸困难及阿片类药物需求轻度减少相关。作者认为,设备完善的普通病房对特定患者可能是ICU的可行替代。
要点
- 不插管医嘱急性呼吸衰竭患者接受无创通气,合并出院存活率56%(95%CI 49-64%),1年存活率32%(95%CI 21-45%)。
- 不插管医嘱患者出院存活率因病因不同:COPD 68%、肺水肿68%、肺炎41%、恶性肿瘤37%。
- 普通病房与ICU接受无创通气的不插管医嘱患者存活率相当。
- 幸存者生活质量较基线未降低,但评估此结局的研究很少;无研究评估死亡质量。
- 仅舒适治疗医嘱患者中,单项研究显示无创通气与呼吸困难及阿片类药物需求轻度减少相关。
适用人群与场景
- 纳入在ICU或普通病房接受无创通气且已预设不插管或仅舒适治疗医嘱的患者。
- 研究类型为所有设计类型,检索时间自建库至2017年1月1日。
研究设计与关键结果
- 纳入27项研究2020例不插管医嘱患者和3项研究200例仅舒适治疗医嘱患者。
- 不插管医嘱患者接受无创通气后合并出院存活率56%(95%CI 49-64%),1年存活率32%(95%CI 21-45%)。
- 不插管医嘱患者出院存活率:COPD 68%、肺水肿68%、肺炎41%、恶性肿瘤37%。
- 普通病房与ICU接受无创通气的不插管医嘱患者存活率相当。
- 幸存者生活质量较基线未降低,但评估此结局的研究很少;无研究评估死亡质量。
- 仅舒适治疗医嘱患者中,单项研究显示无创通气与呼吸困难及阿片类药物需求轻度减少相关。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,数据提取遵循观察性研究Meta分析(MOOSE)指南,数据质量用改良纽卡斯尔-渥太华量表评估。
- 局限:幸存者生活质量评估研究很少;无研究评估死亡质量;仅舒适治疗医嘱患者的证据仅来自单项研究;作者指出幸存者生活质量、非幸存者死亡质量及无创通气对仅舒适治疗医嘱患者的影响等关键问题仍 largely unanswered。
对床旁实践的改变
- 作者认为,对特定不插管医嘱患者,在设备完善的普通病房提供无创通气可能是ICU的可行替代。
- 不插管医嘱患者接受无创通气后出院和1年存活率较高,幸存者生活质量较基线未降低,但相关数据有限。
- 仅舒适治疗医嘱患者中,单项研究显示无创通气与呼吸困难及阿片类药物需求轻度减少相关。
- 幸存者生活质量、非幸存者死亡质量及无创通气对仅舒适治疗医嘱患者的影响等关键问题仍 largely unanswered。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the effectiveness of noninvasive ventilation in patients with acute respiratory failure and do-not-intubate or comfort-measures-only orders.
DATA SOURCES: MEDLINE, EMBASE, CINAHL, Scopus, and Web of Science from inception to January 1, 2017.
STUDY SELECTION: Studies of all design types that enrolled patients in the ICU or hospital ward who received noninvasive ventilation and had preset do-not-intubate or comfort-measures-only orders.
DATA EXTRACTION: Data abstraction followed Meta-analysis of Observational Studies in Epidemiology guidelines. Data quality was assessed using a modified Newcastle-Ottawa Scale.
DATA SYNTHESIS: Twenty-seven studies evaluating 2,020 patients with do-not-intubate orders and three studies evaluating 200 patients with comfort-measures-only orders were included. In patients with do-not-intubate orders, the pooled survival was 56% (95% CI, 49-64%) at hospital discharge and 32% (95% CI, 21-45%) at 1 year. Hospital survival was 68% for chronic obstructive pulmonary disease, 68% for pulmonary edema, 41% for pneumonia, and 37% for patients with malignancy. Survival was comparable for patients treated in a hospital ward versus an ICU. Quality of life of survivors was not reduced compared with baseline, although few studies evaluated this. No studies evaluated quality of dying in nonsurvivors. In patients with comfort-measures-only orders, a single study showed that noninvasive ventilation was associated with mild reductions in dyspnea and opioid requirements.
CONCLUSIONS: A large proportion of patients with do-not-intubate orders who received noninvasive ventilation survived to hospital discharge and at 1 year, with limited data showing no decrease in quality of life in survivors. Provision of noninvasive ventilation in a well-equipped hospital ward may be a viable alternative to the ICU for selected patients. Crucial questions regarding quality of life in survivors, quality of death in nonsurvivors, and the impact of noninvasive ventilation in patients with comfort-measures-only orders remain largely unanswered.
参考来源
- Wilson ME, Majzoub AM, Dobler CC, et al. Noninvasive Ventilation in Patients With Do-Not-Intubate and Comfort-Measures-Only Orders: A Systematic Review and Meta-Analysis. Crit Care Med. 2018. PMID: 29498939. doi:10.1097/CCM.0000000000003082
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。